Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Nintedanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Nintedanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Niraparib	PARP Inhibitor	Solid Tumour
Molecule Niraparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Olomorasib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Olomorasib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Olutasidenib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Olutasidenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Onvansertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Onvansertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Orantinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Orantinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Pamiparib	PARP Inhibitor	Solid Tumour
Molecule Pamiparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Pazopanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Pazopanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Pemigatinib	FGFR Inhibitor	Solid Tumour
Molecule Pemigatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Peposertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Peposertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Pimasertib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Pimasertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Pralsetinib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Pralsetinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor

Nintedanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Niraparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Olomorasib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Olutasidenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Onvansertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Orantinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Pamiparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Pazopanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Pemigatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Peposertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Pimasertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Pralsetinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor

‹ 1 … 6 7 8 9 10 … 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Nintedanib

Niraparib

Olomorasib

Olutasidenib

Onvansertib

Orantinib

Pamiparib

Pazopanib

Pemigatinib

Peposertib

Pimasertib

Pralsetinib

Nintedanib

Niraparib

Olomorasib

Olutasidenib

Onvansertib

Orantinib

Pamiparib

Pazopanib

Pemigatinib

Peposertib

Pimasertib

Pralsetinib